首页> 外文期刊>Drug Design, Development and Therapy >Evaluation of the stability of linezolid in aqueous solution and commonly used intravenous fluids
【24h】

Evaluation of the stability of linezolid in aqueous solution and commonly used intravenous fluids

机译:利奈唑胺在水溶液和常用静脉输液中的稳定性评估

获取原文
       

摘要

Purpose: The aim was to evaluate the stability of linezolid in commonly used intravenous fluids and in aqueous solution to determine the kinetics of degradation and shelf-life values at alkaline pH values. Methods: Forced degradation studies were performed on linezolid in solution to develop a validated high-performance liquid chromatography analysis. Sodium chloride 0.9%, sodium lactate, and glucose 5% and glucose 10% solution containing 2.0 mg/mL linezolid were stored at 25.0°C (±0.1°C) for 34 days. The effect of temperature on the stability of linezolid in 0.1 M sodium hydroxide solution was investigated to determine the activation energy. The degradation rates of linezolid at selected pH values at 70.0°C and the influence of ionic strength were also examined. Activation energy data were applied to determine the shelf-life values at selected pH values, and a pH rate profile was constructed over the pH range of 8.7–11.4. The stability of intravenous linezolid (Zyvox?) solution was evaluated by storing at 70.0°C for 72 hours. Results: Linezolid was found to maintain >95.0% of its initial concentration after storage at 25.0°C for 34 days in sodium lactate, 0.9% in sodium chloride, and 5% and 10% in glucose solutions. Linezolid was degraded at alkaline pH values by first-order kinetics. Activation energy data showed that temperature, but not ionic strength, influenced the degradation rate significantly. An activation energy of 58.22 kJ/mol was determined for linezolid in 0.1 M sodium hydroxide solution. Linezolid was least stable at high pH values and at elevated temperatures. It was determined that linezolid has adequate stability for the preparation of intravenous fluids for clinical administration. Conclusion: Linezolid was found to have a shelf life of 34 days at 25°C when added to sodium lactate, 0.9% sodium chloride, and 5% and 10% glucose solutions. It was least stable at high pH values and at elevated temperatures.
机译:目的:目的是评估利奈唑胺在常用的静脉输液和水溶液中的稳定性,以确定在碱性pH值下的降解动力学和保质期。方法:在溶液中利奈唑胺上进行了强制降解研究,以开发一种经过验证的高效液相色谱分析方法。将含有2.0 mg / mL利奈唑胺的0.9%氯化钠,乳酸钠和5%葡萄糖和10%葡萄糖溶液在25.0°C(±0.1°C)下保存34天。研究了温度对利奈唑胺在0.1 M氢氧化钠溶液中稳定性的影响,以确定活化能。还考察了在70.0°C选定的pH值下利奈唑胺的降解速率以及离子强度的影响。应用活化能数据确定在选定的pH值下的保质期值,并在8.7-11.4的pH范围内构建pH速率分布图。通过在70.0℃下储存72小时来评估静脉内利奈唑胺(Zyvox α)溶液的稳定性。结果:发现利奈唑胺在25.0°C下于乳酸钠中储存34天,在氯化钠中为0.9%,在葡萄糖溶液中分别为5%和10%后,保持其初始浓度的> 95.0%。利奈唑胺在碱性pH值下通过一级动力学降解。活化能数据表明,温度而不是离子强度显着影响降解速率。在0.1 M氢氧化钠溶液中测得的利奈唑胺的活化能为58.22 kJ / mol。利奈唑胺在高pH值和高温下最不稳定。已确定利奈唑胺具有足够的稳定性,可用于制备临床用静脉注射液。结论:发现将利奈唑胺添加到乳酸钠,0.9%氯化钠,5%和10%葡萄糖溶液中后,在25°C下的保质期为34天。在高pH值和高温下最不稳定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号